亚辉龙 (688575)
Shenzhen YHLO Biotech Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 57042.68
- Circulating A-Shares(W): 57042.68
- Earnings Per Share(RMB): 0.1100
- Net Assets Per Share(RMB): 4.7383
- Operating Revenue(W RMB): 128671.14
- Total Profit(W RMB): 6447.77
- **Net Profit Attributable to Parent(W RMB) **: 6042.09
- Net Profit Growth Rate(%): -72.36
- Weighted Return on Equity(%): 2.1700
- Operating Cash Flow Per Share(RMB): 0.1140
- Undistributed Profit Per Share(RMB): 2.4611
- Capital Reserve Per Share(RMB): 0.8529
2. Main Business
The main business covers:
- Research, production, and sales of in-vitro diagnostic instruments and supporting reagents primarily based on chemiluminescence immunoassay
- Agency sales business for some non-self-produced medical device products
3. Company Basic Information
- Company Name: Shenzhen YHLO Biotech Co., Ltd.
- Listing Date: 2021-05-17
- Industry: Pharmaceutical Manufacturing
- Address: Building 1, YHLO Biotech Factory Area, Baolong 2nd Road, Baolong Street, Longgang District, Shenzhen City, Guangdong Province
- Website: https://www.szyhlo.com/
- Company Profile: The company was established in 2015 and transformed into a joint stock company, focusing on the research, production, and sales of in-vitro diagnostic instruments and supporting reagents primarily based on chemiluminescence immunoassay.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shenzhen Puhui Zhonglian Industrial Investment Co., Ltd. | General Legal Person | 4645.10 | 8.14 |
| 2 | Shenzhen Yingfu Huizhi Private Securities Fund Management Co., Ltd. - Yingfu Zengxin Yinhe Yixing No. 5 Private Securities Investment Fund | Private Securities Investment Fund | 1523.91 | 2.67 |
| 3 | Jiaxing Ruiyao Venture Capital Partnership (Limited Partnership) | General Legal Person | 1278.08 | 2.24 |
| 4 | Hainan Shuofeng Private Fund Management Partnership (Limited Partnership) - Shuofeng Changjiang No. 3 Private Securities Investment Fund | Private Securities Investment Fund | 1124.71 | 1.97 |
| 5 | Ningbo Pengrui Enterprise Management Partnership (Limited Partnership) | General Legal Person | 1055.76 | 1.85 |
| 6 | Huabao CSI Medical ETF | Fund | 965.16 | 1.69 |
| 7 | Shanghai Liyi Investment Management Partnership (Limited Partnership) - Suzhou Lirun Equity Investment Center (Limited Partnership) | General Legal Person | 605.49 | 1.06 |
| 8 | Penghua SSE STAR 100 ETF联接基金A类 | Fund | 0.14 | 0.00 |
5. Concept Sectors
- Gene Concept
- Assisted Reproduction
- Hepatitis Concept
- DeepSeek
- Margin Trading & Securities Lending
- Intensive Research
- Heavy Private Placement Holdings
- SSE 380
- STAR Market Biotech
- STAR 100
Remarks
- Data update date: 2025-11-07
- Data source: Public Market Information